Either you have JavaScript disabled or your browser does not support Javascript . To work properly, this page requires JavaScript to be enabled.
How to enable JavaScript in your browser?

Testosterone Replacement and Dutasteride Effectiveness (TRADE).

Next Previous
Trial Profile

Testosterone Replacement and Dutasteride Effectiveness (TRADE).

Status: Completed
Phase of Trial: Phase IV

Latest Information Update: 28 Jun 2023

Price :
$35 *
Note:
  • Adis is an information provider.
  • Final gross price and currency may vary according to local VAT and billing address.
  • Your purchase entitles you to full access to the information contained in our trial profile at the time of purchase.
  • A link to download a PDF version of the trial profile will be included in your email receipt.

At a glance

  • Drugs Dutasteride (Primary) ; Testosterone
  • Indications Benign prostatic hyperplasia
  • Focus Pharmacogenomic; Therapeutic Use
  • Acronyms TRADE

Most Recent Events

  • 17 Aug 2012 Actual initiation date changed from 1 Jun 2005 to 1 Mar 2005 as reported by ClinicalTrials.gov.
  • 17 Aug 2012 Actual end date (1 Dec 2010) added as reported by ClinicalTrials.gov record.
  • 14 May 2011 Primary endpoint 'Prostate volume' has been met, as published in the Journal of Urology.

You need to be a logged in or subscribed to view this content

Request demo (opens in a new window)
If your organization or you do not have a subscription, try one of the following: If your organization has a subscription, there are several access options, even while working remotely:
  • Working within your organization’s network
  • with username/password or try to via your institution
  • Persisted access using your organization’s identifier stored in your user browser for 90 days
Back to top